Driving innovation in rare disease treatment and clinical diagnostics through research, science, and care.
Wynolze Pharmaceuticals Pvt Ltd is committed to pioneering therapeutic advancements in rare disease and clinical diagnostics. Our team of scientists and clinicians is dedicated to research that transforms lives through precision medicine and diagnostics.
Using NGS technology for accurate diagnosis of rare genetic disorders.
Advanced ELISA and qPCR-based biomarker profiling.
ISO-compliant labs offering rapid, reliable diagnostics with expert analysis.
Wynolze develops scientifically formulated Ayurvedic syrup medicines tailored for rare and chronic conditions, blending traditional herbal wisdom with modern pharmaceutical standards.
Ayurvedic formulation for chronic respiratory disorders such as bronchial asthma and persistent cough. Contains Tulsi, Vasaka, and Yashtimadhu.
Liver health tonic formulated with Kalmegh, Bhumiamalaki, and Triphala — supports detoxification and improves liver enzyme function in rare metabolic syndromes.
Herbal neurotonic for pediatric and neurological care — includes Brahmi, Shankhpushpi, and Jatamansi to enhance cognitive function and calm the nervous system.
Supports heart health using Ayurvedic herbs such as Arjuna, Pushkarmool, and Guggulu. Helps manage cholesterol and improve cardiac efficiency.
A potent nootropic syrup with Brahmi, Shankhpushpi, and Mandukaparni — improves memory, mental alertness, and neurological balance.
Our GMP-certified facilities manufacture a range of rare disease medicines and syrups with high-precision cleanroom protocols and automated quality control systems.
Focused R&D on metabolic and pediatric rare diseases.
Working with academic and clinical institutions for co-discovery.
Using machine learning to accelerate molecule screening and testing.